pI: 6.6019 |
Length (AA): 1588 |
MW (Da): 181311 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 6 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
194 | 336 | 5cwo (A) | 93 | 218 | 36.00 | 0.023 | 0.85 | 0.44245 | -0.57 |
244 | 1343 | 1st6 (A) | 10 | 1056 | 13.00 | 0 | 1 | 0.671395 | 0.59 |
265 | 1386 | 4cmq (A) | 23 | 1318 | 13.00 | 0 | 0.71 | 0.553249 | 1.47 |
286 | 369 | 4o9b (A) | 252 | 334 | 23.00 | 0 | 0.01 | 0.422597 | -2.61 |
294 | 451 | 5cwj (A) | 2 | 155 | 23.00 | 0 | 0.7 | 0.449196 | -1.86 |
1333 | 1572 | 5dac (A) | 196 | 1297 | 49.00 | 0 | 1 | 0.629534 | 0.22 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | ME49 Tachyzoite. | Gregory |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | VEG Tachyzoite, ME49 Bradyzoite. | Gregory Sibley/Greg |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 20-40% percentile | ME49 merozoite, ME49 Oocyst. | Hehl AB Fritz HM |
Gregory | ToxoDB |
Hehl AB | Asexual expansion of Toxoplasma gondii merozoites is distinct from tachyzoites and entails expression of non-overlapping gene families to attach, invade, and replicate within feline enterocytes. |
Sibley/Greg | ToxoDB |
Fritz HM | Transcriptomic analysis of toxoplasma development reveals many novel functions and structures specific to sporozoites and oocysts. |
Ortholog group members (OG5_127792)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT2G31970 | DNA repair protein RAD50 |
Babesia bovis | BBOV_III009970 | conserved hypothetical protein |
Brugia malayi | Bm1_51725 | rad50 family protein |
Candida albicans | CaO19.9217 | similar to S.cerervisiae RAD50 (YNL250W) protein involved in dsDNA break repair |
Candida albicans | CaO19.1648 | similar to S. cerevisiae RAD50 (YNL250W) protein involved in dsDNA break repair |
Caenorhabditis elegans | CELE_T04H1.4 | Protein RAD-50, isoform A |
Cryptosporidium hominis | Chro.10270 | RAD50 DNA repair protein-related |
Cryptosporidium hominis | Chro.10271 | RAD50 |
Cryptosporidium parvum | cgd1_2410 | RAD50 |
Dictyostelium discoideum | DDB_G0292786 | DNA recombination/repair protein |
Drosophila melanogaster | Dmel_CG6339 | CG6339 gene product from transcript CG6339-RE |
Echinococcus granulosus | EgrG_000773300 | dna repair protein rad50 |
Entamoeba histolytica | EHI_079960 | hypothetical protein, conserved |
Echinococcus multilocularis | EmuJ_000773300 | dna repair protein rad50 |
Homo sapiens | 10111 | RAD50 homolog (S. cerevisiae) |
Leishmania braziliensis | LbrM.28.0550 | RAD50 DNA repair-like protein |
Leishmania donovani | LdBPK_280560.1 | RAD50 DNA repair-like protein |
Leishmania infantum | LinJ.28.0560 | RAD50 DNA repair-like protein |
Leishmania major | LmjF.28.0530 | RAD50 DNA repair-like protein |
Leishmania mexicana | LmxM.28.0530 | RAD50 DNA repair-like protein |
Loa Loa (eye worm) | LOAG_02334 | rad50 family protein |
Mus musculus | ENSMUSG00000020380 | RAD50 homolog (S. cerevisiae) |
Neospora caninum | NCLIV_029780 | DNA repair protein RAD50, putative |
Oryza sativa | 4329409 | Os02g0497500 |
Plasmodium berghei | PBANKA_0104600 | DNA repair protein RAD50, putative |
Plasmodium falciparum | PF3D7_0605800 | DNA repair protein RAD50, putative |
Plasmodium knowlesi | PKNH_1144400 | DNA repair protein RAD50, putative |
Plasmodium vivax | PVX_113460 | DNA repair protein RAD50, putative |
Plasmodium yoelii | PY00626 | unnamed protein product |
Saccharomyces cerevisiae | YNL250W | Rad50p |
Schistosoma japonicum | Sjp_0009740 | DNA repair protein RAD50, putative |
Schistosoma japonicum | Sjp_0079430 | ko:K01554 RAD50 homolog [EC:3.6.-.-], putative |
Schistosoma mansoni | Smp_127050 | DNA repair protein RAD50 |
Schmidtea mediterranea | mk4.018177.00 | DNA repair protein rad-50 |
Schmidtea mediterranea | mk4.011527.01 | DNA repair protein rad-50 |
Schmidtea mediterranea | mk4.010022.01 | Rad50-like protein |
Schmidtea mediterranea | mk4.009021.00 | DNA repair protein rad-50 |
Trypanosoma brucei gambiense | Tbg972.11.9380 | RAD50 DNA repair-like protein, putative |
Trypanosoma brucei | Tb11.v5.0573 | RAD50 DNA repair-like protein, putative |
Trypanosoma brucei | Tb11.v5.0572 | RAD50 DNA repair-like protein, putative |
Trypanosoma brucei | Tb927.11.8210 | RAD50 DNA repair-like protein |
Trypanosoma congolense | TcIL3000.11.8750 | RAD50 DNA repair-like protein |
Trypanosoma cruzi | TcCLB.508817.70 | DNA repair protein RAD50, putative |
Trypanosoma cruzi | TcCLB.503799.10 | DNA repair protein RAD50, putative |
Toxoplasma gondii | TGME49_257180 | RecF/RecN/SMC N terminal domain-containing protein |
Theileria parva | TP02_0154 | RAD50 DNA repair protein, putative |
Trichomonas vaginalis | TVAG_332600 | DNA repair protein Rad50 |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb11.01.0340 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (3 days) | alsford |
Tb11.01.0340 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb11.01.0340 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb11.01.0340 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_T04H1.4 | Caenorhabditis elegans | embryonic lethal | wormbase |
PBANKA_0104600 | Plasmodium berghei | Dispensable | plasmo |
TGME49_257180 this record | Toxoplasma gondii | Probably essential | sidik |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.